DSP Healthcare Fund Direct-IDCW
NAV
₹27.6560
as on 18 Sep 2025, 09:00 PM
₹0.1060(0.38%)
Last Change
Scheme Information
DSP Healthcare Fund Direct-IDCW
as of 31 Aug 2025, 05:30 AM
₹3,106.92 Cr
0.59%
2.21%
Open-End
Growth
Exit load of 0.50% if redeemed within 1 month.
BSE Healthcare Total Return Index
View
Sectors Holding in this Mutual Fund
Healthcare
95.72%
₹2,973.95 Cr
Insurance
1.43%
₹44.43 Cr
Others
2.85%
₹88.55 Cr
Healthcare
95.72%
₹2,973.95 Cr
Insurance
1.43%
₹44.43 Cr
Others
2.85%
₹88.55 Cr
Cipla Ltd.
8.86%
₹275.27 Cr
Cohance Lifesciences Ltd.
8.81%
₹273.72 Cr
Sun Pharmaceutical Industries Ltd.
8.70%
₹270.30 Cr
Ipca Laboratories Ltd.
8.16%
₹253.52 Cr
Gland Pharma Ltd.
4.94%
₹153.48 Cr
Others
60.53%
₹1,880.62 Cr
Cipla Ltd.
8.86%
₹275.27 Cr
Cohance Lifesciences Ltd.
8.81%
₹273.72 Cr
Sun Pharmaceutical Industries Ltd.
8.70%
₹270.30 Cr
Ipca Laboratories Ltd.
8.16%
₹253.52 Cr
Gland Pharma Ltd.
4.94%
₹153.48 Cr
Others
60.53%
₹1,880.62 Cr
Funds in this Category
This fund's returns: 26.38%
ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund Direct - Growth
Min. Investment
₹100
30.85
Category Returns
20.02%
30.85%
3Y Returns
30.85 %
UTI Healthcare Fund Direct-Growth
Min. Investment
₹500
27.94
Category Returns
20.02%
30.85%
3Y Returns
27.94 %
SBI Healthcare Opportunities Fund Direct Plan-Growth
Min. Investment
₹500
27.49
Category Returns
20.02%
30.85%
3Y Returns
27.49 %
About DSP Healthcare Fund Direct-IDCW
DSP Healthcare Fund Direct-IDCW scheme return performance in last 1 year is -0.98%, in last 3 years is 102.10% and 338.13% since scheme launch. The min. SIP amount to invest in this scheme is ₹100.
Scheme Details
AUM: | ₹3,106.92 Cr |
Category: | Equity: Sectoral-Pharma |
Launch Date: | Invalid date |
Fund Type: | Open-End |
AMC Information
DSP Mutual Fund
Address
Investment Performance
₹ 1,00,000
would have given a return of
₹1,10,871
₹1,21,647
₹1,94,119
₹2,02,095
Bank Account
Fixed Deposit
Regular Mutual Fund
This Fund on Paytm Money
This Mutual Fund
Profit (absolute return)
₹1,02,095
102.10%
Investment Returns
Scheme Riskometer
Investors understand that their principal will be at very high risk